ProCE Banner Activity

CE / CME

Medical Minute 3: Optimizing Care and Reducing Disparities for Children and Adults With Moderate to Severe Atopic Dermatitis: Practical Strategies for Inner-City Communities – Case 2

Video

Physician Assistants/Physician Associates: 0.25 AAPA Category 1 CME credit

Physicians: Maximum of 0.25 AMA PRA Category 1 Credit

Nurse Practitioners: 0.25 Nursing contact hour

Released: March 10, 2023

Expiration: March 09, 2024

No longer available for credit.

Share

Faculty

Heather Woolery-Lloyd

Heather Woolery-Lloyd, MD

Director, Skin of Color Division
Dr. Philip Frost Department of Dermatology and Cutaneous Surgery
University of Miami Miller School of Medicine
Miami, Florida

Leighanne McGill

Leighanne McGill, PA-C

Dermatology Physician Assistant
Diplomate Fellow
Society of Dermatology Physician Assistants
New York, New York

Provided by

ProCE Banner
ProCE Banner

Supporters

This activity is supported by educational grants from

Regeneron Pharmaceuticals

Sanofi

Target Audience

Dermatology physicians and advanced practice providers who care for patients with moderate to severe atopic dermatitis within inner city communities.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify potential healthcare disparities impacting patients in inner-city communities with moderate to severe atopic dermatitis

  • Incorporate strategies that are aimed at providing optimal management of moderate to severe atopic dermatitis to patients impacted by healthcare disparities in inner-city communities

Disclosure

Clinical Care Options, LLC (CCO) and Partners for Advancing Clinical Education (PACE) require instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO and PACE policy. CCO and PACE are committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Heather Woolery-Lloyd, MD: consultant/speaker/advisor: Allergan, Arcutis, Bausch + Lomb, Eirion Therapeutics, Galderma, Incyte, Johnson & Johnson, Lilly, Merz, Ortho Dermatologics, Pfizer, Sanofi.

Leighanne McGill, PA-C, has no relevant financial relationships to disclose.

The planners and content peer reviewers from Partners for Advancing Clinical Education, Clinical Care Options, LLC, and Practicing Clinicians Exchange do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.25 hours. To successfully complete this activity and receive credit, learners must follow these steps during the period from March 10, 2023, through March 09, 2024:

  1. Create an account or Login at https://practicingclinicians.com  
  2. Read the target audience, learning objectives, and faculty disclosures
  3. View and study the content in its entirety
  4. Submit answers to the post-test questions and evaluation questions online

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by clicking the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

The program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Partners for Advancing Clinical Education, Practicing Clinicians Exchange, or any educational supporter.

Accreditation

Joint Accreditation Statement
Joint AccreditationIn support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Physician Continuing Medical Education
CCO designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Joint Accreditation Statement
Joint AccreditationIn support of improving patient care, Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

ANCC Credit Designation
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.25 contact hours.

 

AAPA Credit Designation
Joint AccreditationPartners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until March 09, 2024. PAs should only claim credit commensurate with the extent of their participation.